Previous close | 2.8000 |
Open | 3.2000 |
Bid | 3.4000 |
Ask | 3.7000 |
Strike | 2.50 |
Expiry date | 2024-12-20 |
Day's range | 3.2000 - 3.6200 |
Contract range | N/A |
Volume | |
Open interest | 42 |
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
On May 13, 2024, Richard Mott, a Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 120,000 shares of the company, as reported in a recent SEC Filing.